Gina LaRocca, MD Email Gina LaRocca
- ASSOCIATE PROFESSOR | Medicine, Cardiology
- ASSOCIATE PROFESSOR | Diagnostic, Molecular and Interventional Radiology
- Cardiovascular Disease (Heart Disease)
- Hospital Affiliation
- The Mount Sinai Hospital
Gina LaRocca, MD, MHSc is the Associate Director of Advanced Cardiovascular Imaging / Cardiac CT and Cardiac MRI. She is the Fellowship Director of Advanced Cardiovascular Imaging. She is an Associate Professor of Medicine in Cardiology at Mount Sinai’s Zena and Michael A. Wiener Cardiovascular Institute and the Marie-Josée and Henry R. Kravis Center for Cardiovascular Health. She is also Associate Professor of Radiology at Mount Sinai.
Dr. LaRocca completed a rigorous five year combined cardiology fellowship in pediatric and adult cardiology at Columbia University Medical Center. The five years following, she was Assistant Professor of Medicine, Pediatrics and Radiology at Weill Cornell Medical College. She developed the first Adult Congenital Heart Disease program at Weill Cornell. Dr. LaRocca was responsible for diagnosing and treating adult patients with complex congenital heart disease and became the liaison between adult and pediatric cardiology.
In 2012, Dr. LaRocca joined the National Heart, Lung and Blood Institute of the National Institutes of Health (NIH) as a physician-scientist and an advanced cardiovascular imaging fellow in MRI and CTA. Her cutting-edge cardiac MRI research lead to a publication in 2014 in the Journal of Cardiac MRI entitled: High Spatial and Temporal Resolution Retrospective Cardiac Cine MRI from Shortened Free Breathing Real-Time Acquisitions.
During this time at the NIH, she was privileged to work with outstanding scientists and was involved in extensive research in novel cardiovascular biomarkers. She played a key role in the AGES-Reykjavik Study, a joint program between the Icelandic Heart Association and the NIH. Dr. LaRocca subsequently earned the prestigious NIH Intramural Research Curriculum Certificate with commendation. Her NIH research has been introduced both nationally and internationally at the American Heart Association and European Society of Cardiology.
Dr. LaRocca received her Master’s degree in Health Sciences in Clinical Research at Duke University. In May 2015 at Commencement exercises, she was recognized by the Dean of the School of Medicine for her Master’s thesis in cardiovascular biomarkers.
In 2017, Dr. LaRocca presented her NIH research entitled ‘Fibrosis as Measured by the Biomarker, TIMP1, Predicts Mortality in AGES-Reykjavik Study’ as a prestigious Late Breaking Clinical Trial with simultaneous publication at the European Society of Cardiology.
In 2019, Dr. LaRocca published in the world renown Proceedings of the National Academy of Sciences entitled “Multipotent Fetal-derivedCdx2 cells from Placenta Regenerate the Heart’.
Dr. LaRocca has received awards in academic teaching at the University of Connecticut. She was chosen as outstanding Junior Faculty at Weill Cornell Medical College in 2011, one of twelve faculty awarded by the Chairman of Medicine.
She is a peer-reviewer for numerous medical journals.
In addition to board certification in Cardioavascular medicine, Dr. LaRocca is also board certified in cardiac MRI, cardiac CTA and cardiac echocardiography.
American Board of Internal Medicine
- Heart Disease
MD, Creighton University
Residency, Pediatric Medicine
University of Connecticut
University of Connecticut
Fellowship, Advance Cardiac Imaging
National Institutes of Health
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.LaRocca did not report having any of the following types of financial relationships with industry during 2021 and/or 2022: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.